Key facts
- This page summarizes Vickie L. Capps's Form 4 filing for Orthofix Medical Inc. (OFIX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 13 Mar 2025, 16:21.
Vickie L. Capps - 11 Mar 2025 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)
- Reporting relationship
- Director
- Issuer ticker
- OFIX
- Reported as of
- 11 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Mar 2025, 16:21:57 UTC
- Prior SEC filing
- 07 Nov 2024
- Next SEC filing
- 06 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ J. Andres Cedron, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vickie L. Capps filed Form 4 for Orthofix Medical Inc. (OFIX) on 13 Mar 2025.
Change
- Previous filing in this sequence was filed on 07 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OFIX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,093
- Change %
- Price
- $0.000000
- Shares after
- 3,093
- Date
- 11 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OFIX
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +35,270
- Change %
- Price
- $0.000000
- Shares after
- 35,270
- Date
- 11 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 35,270
- Exercise price
- $17.10
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2025 or (ii) the date on which the issuer holds its 2025 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.
Footnote F2
The options vest and become exercisable with respect to 25% of the shares covered thereby on the first, second, third and fourth anniversary of the Grant Date.